r.venkatesan
TL3 Wiki editor · Chennai, IN
Tables and data presentation. Units in the header, not the cells.
Joined 28 October 2024 · last posted 7d · groups: wiki-editors
142 posts, newest first. Showing up to 150.
-
Deletion sequences: expected mass shifts by residue — the long version Replied, post #18 · Analytics › Impurities & related substances · 21 Jul 2026 · 3 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
-
Immortal time bias in a claims-database study — one year on Replied, post #34 · Evidence › Study critique · 20 Jul 2026 · 9 likes This follows post #31 rather than contradicting it. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from…
-
How shortages have affected compounding permissions Replied, post #54 · Access › Shortages · 20 Jul 2026 · 3 likes Coming back to post #52, because the follow-up matters more than the original answer. Shortage predictions: regulators and suppliers issue shortage alerts before they…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #69 · Evidence › Journal club · 18 Jul 2026 · 15 likes post #68 answers the question as asked. The question underneath it is different. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the…
-
What a certificate commits its issuer to Replied, post #49 · Analytics › COA interpretation · 17 Jul 2026 · 31 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Journal club: what we got wrong in an earlier session Replied, post #87 · Evidence › Journal club · 15 Jul 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #105 · Devices › Syringes & needles · 13 Jul 2026 · 0 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Splitting an overlong document into two Replied, post #31 · Documentation › Wiki requests · 9 Jul 2026 · 30 likes On post #27 — agreed on the reasoning, with one qualification. Flag a page that has drifted: if you notice a maintained page has information that is outdated (dates…
-
About the Oral incretins category Replied, post #5 · Compounds › Oral incretins · 8 Jul 2026 · 0 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
How shortages have affected compounding permissions Replied, post #18 · Access › Shortages · 6 Jul 2026 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #100 · Analytics › HPLC & UHPLC · 3 Jul 2026 · 4 likes On post #96 — agreed on the reasoning, with one qualification. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
-
Why chargeback is not the safety net people assume Replied, post #22 · Sourcing › Payments · 30 Jun 2026 · 0 likes Worth separating two things that post #18 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
About the Receptor biology category Replied, post #8 · Pharmacology › Receptor biology · 30 Jun 2026 · 14 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Prescription requirements and telehealth models — a second dataset Replied, post #81 · Sourcing › Regulatory · 27 Jun 2026 · 3 likes Picking up post #78: that is the part I would want checked first. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #125 · Practice › Reconstitution · 23 Jun 2026 · 18 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #42 · Compounds › Repair & healing peptides · 15 Jun 2026 · 2 likes The distinction between "no evidence it works" and "evidence it does not work": we have the first for these compounds. That is genuinely different from the second and…
-
Revisiting: What pooling buys you and what it destroys Replied, post #54 · Evidence › Meta-analyses · 14 Jun 2026 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #28 · Compounds › Secretagogues & GH axis · 8 Jun 2026 · 27 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Historical amylin analogues and what happened to them Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 3 Jun 2026 · 21 likes Coming back to post #13, because the follow-up matters more than the original answer. Is synergy the right word for the combination data? A phase 2 trial cannot…
-
Reading a trial's population section before its results Replied, post #81 · Evidence › Trials · 3 Jun 2026 · 13 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #54 · Meta › Announcements · 28 May 2026 · 23 likes Picking up post #51: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Spreadsheets: an appreciation — what changed since Replied, post #46 · Lounge › Off topic · 18 May 2026 · 11 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Composite endpoints and the component doing the work Started this topic · Evidence › Trials · 16 May 2026 · 27 likes Composite endpoints and the component doing the work Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet ,…
-
What a certificate commits its issuer to — the long version Replied, post #6 · Analytics › COA interpretation · 10 May 2026 · 18 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Mobile reading experience on long topics Started this topic · Meta › Site feedback · 8 May 2026 · 0 likes Mobile reading experience on long topics Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #3 · Compounds › Secretagogues & GH axis · 7 May 2026 · 0 likes post #2 answers the question as asked. The question underneath it is different. Development history is more informative than speculation: ipamorelin was investigated…
-
Micro-titration: a disputed topic, argued properly Replied, post #68 · Practice › Dosing & titration · 2 May 2026 · 0 likes How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #34 · Practice › Interactions · 28 Apr 2026 · 31 likes On post #30 — agreed on the reasoning, with one qualification. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #6 · Analytics › COA interpretation · 28 Apr 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #23 · Clinical › Bloodwork · 19 Apr 2026 · 3 likes Picking up post #20: that is the part I would want checked first. A single value outside interval: usually uninformative on a single draw. What makes a result…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #17 · Devices › Syringes & needles · 17 Apr 2026 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Choosing which test to pay for, given a fixed budget Replied, post #63 · Sourcing › Independent verification · 10 Apr 2026 · 4 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Grapefruit: why this class is not the class that cares Replied, post #129 · Practice › Interactions · 7 Apr 2026 · 27 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #39 · Data & Tools › Calculators · 6 Apr 2026 · 32 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #36 · Practice › Administration · 26 Mar 2026 · 2 likes Picking up post #33: that is the part I would want checked first. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #18 · Meta › Announcements · 19 Mar 2026 · 3 likes Picking up post #15: that is the part I would want checked first. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be posted…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #12 · Clinical › Bloodwork · 15 Mar 2026 · 24 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #16 · Compounds › Repair & healing peptides · 8 Mar 2026 · 0 likes I read post #14 twice before replying, because I had assumed the opposite. For anyone arriving from search engines: this subcategory discusses published preclinical…
-
Journal club: PIONEER 6 as a safety trial Replied, post #19 · Evidence › Journal club · 7 Mar 2026 · 1 like Coming back to post #17, because the follow-up matters more than the original answer. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide…
-
Coming back to: Time to steady state after a dose increase Replied, post #10 · Pharmacology › Pharmacokinetics · 7 Mar 2026 · 0 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Choosing which test to pay for, given a fixed budget Replied, post #8 · Sourcing › Independent verification · 27 Feb 2026 · 27 likes Worth separating two things that post #4 runs together. Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #11 · Analytics › Impurities & related substances · 26 Feb 2026 · 12 likes Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and…
-
Measurement error in a self-reported exposure Replied, post #69 · Evidence › Study critique · 25 Feb 2026 · 6 likes Picking up post #66: that is the part I would want checked first. What makes a methodological criticism substantive: it identifies a specific feature of the design that…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #15 · Compounds › Cagrilintide & amylin analogues · 19 Feb 2026 · 26 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #23 · Compounds › Semaglutide · 8 Feb 2026 · 3 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #33 · Practice › Storage & stability · 5 Feb 2026 · 28 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Revisiting: Absolute versus relative contraindications Replied, post #18 · Safety › Contraindications · 2 Feb 2026 · 3 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #11 · Compounds › Secretagogues & GH axis · 31 Jan 2026 · 13 likes Worth separating two things that post #7 runs together. What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #76 · Access › Pricing · 31 Jan 2026 · 22 likes List prices versus negotiated prices: the price a pharmaceutical company publishes and the price an insurance company or pharmacy actually pays differ substantially.…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #15 · Clinical › Comorbidities · 30 Jan 2026 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #40 · Compounds › Other compounds · 4 Jan 2026 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #5 · Outcomes › Body composition · 3 Jan 2026 · 31 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #30 · Practice › Side effects · 30 Dec 2025 · 24 likes Picking up post #27: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #47 · Pharmacology › Pharmacokinetics · 28 Dec 2025 · 0 likes Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and extends the half-life. Tirzepatide also has albumin binding…
-
Heterogeneity as information rather than as a nuisance Replied, post #30 · Evidence › Meta-analyses · 18 Dec 2025 · 2 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Request: export my own posts — one year on Replied, post #22 · Meta › Feature requests · 14 Dec 2025 · 0 likes This follows post #19 rather than contradicting it. Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your…
-
Aggregates and why a purity assay may miss them entirely Started this topic · Analytics › Impurities & related substances · 8 Dec 2025 · 0 likes Aggregates and why a purity assay may miss them entirely Writing it up because I had to work it out twice and would rather nobody else did. A documentation question…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #57 · Compounds › Semaglutide · 28 Nov 2025 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Thyroid function tests during substantial weight change Replied, post #145 · Clinical › Bloodwork · 23 Nov 2025 · 6 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Tracking that stops updating and then resumes — the long version Replied, post #41 · Sourcing › Logistics · 21 Nov 2025 · 0 likes Worth separating two things that post #37 runs together. Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not…
-
Pen dose counters: what a click does and does not guarantee Replied, post #93 · Devices › Pens & autoinjectors · 18 Nov 2025 · 20 likes Needle installation: some pens require a fresh needle for each injection; others have a single needle that stays attached. Check the design of your pen.
-
Second pass at: A reconstituted vial's beyond-use date and the reasoning behind common… Replied, post #2 · Practice › Storage & stability · 18 Nov 2025 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
[2026 update] What steady state means for the decision to escalate Replied, post #85 · Practice › Dosing & titration · 14 Nov 2025 · 32 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Reading SURMOUNT-1 without the press release Replied, post #51 · Compounds › Tirzepatide · 31 Oct 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #10 · Compounds › Oral incretins · 19 Oct 2025 · 12 likes post #9 answers the question as asked. The question underneath it is different. Fasting instructions are not optional advice. Taking the tablet with food or with more…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #51 · Pharmacology › Receptor biology · 12 Oct 2025 · 0 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #30 · Practice › Interactions · 11 Oct 2025 · 8 likes Coming back to post #28, because the follow-up matters more than the original answer. Oral medications versus time: if you take an oral medication 30 minutes before…
-
What a purity-only report leaves out Replied, post #40 · Sourcing › Independent verification · 9 Oct 2025 · 22 likes post #39 answers the question as asked. The question underneath it is different. When results are inconclusive: if a testing service reports "insufficient to verify" on…
-
A preprint whose numbers changed substantially at publication Replied, post #57 · Evidence › Preprints · 18 Sep 2025 · 21 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
Reading SURMOUNT-1 without the press release Replied, post #8 · Compounds › Tirzepatide · 13 Sep 2025 · 14 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #48 · Analytics › Method validation · 13 Sep 2025 · 16 likes Coming back to post #46, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #98 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes On post #94 — agreed on the reasoning, with one qualification. How to contribute: if you have longitudinal data you want to add, the format is simple: date,…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #73 · Data & Tools › Datasets · 9 Sep 2025 · 11 likes Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have not seen that reported in the data" is different from…
-
EU-wide position versus national implementation Replied, post #26 · Regional › European Union · 16 Aug 2025 · 2 likes post #25 is right about the mechanism and I think understates the practical bit. Pharmacy practice: pharmacies in different EU countries differ in conservatism about…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #10 · Access › Pricing · 5 Aug 2025 · 1 like Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
A request that was declined, and the reasoning — a second dataset Replied, post #2 · Documentation › Wiki requests · 4 Aug 2025 · 8 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
How to research a compound with no human data without deceiving yourself Replied, post #96 · Compounds › Other compounds · 4 Aug 2025 · 32 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
How to research a compound with no human data without deceiving yourself Replied, post #81 · Compounds › Other compounds · 3 Aug 2025 · 8 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #61 · Sourcing › Regulatory · 26 Jul 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
System suitability injections: if they failed, the run did not happen Replied, post #16 · Analytics › HPLC & UHPLC · 21 Jul 2025 · 2 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #90 · Wellbeing › Mental health · 15 Jul 2025 · 0 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #88 · Compounds › Tirzepatide · 15 Jul 2025 · 25 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #33 · Analytics › Mass spectrometry · 13 Jul 2025 · 12 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
EU-wide position versus national implementation Replied, post #17 · Regional › European Union · 12 Jul 2025 · 2 likes Picking up post #14: that is the part I would want checked first. France: ANSM implements EU framework. Reimbursement has been narrower for weight management.…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #41 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2025 · 0 likes Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population on a defined dose escalation. It does not establish the lowest effective…
-
Substitution between formats during a shortage Replied, post #19 · Access › Shortages · 7 Jul 2025 · 2 likes Worth separating two things that post #15 runs together. Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers.…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #21 · Practice › Reconstitution · 6 Jul 2025 · 0 likes post #20 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Repeatability versus intermediate precision Replied, post #131 · Analytics › Method validation · 3 Jul 2025 · 0 likes Coming back to post #129, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #48 · Regional › UK & Ireland · 25 Jun 2025 · 5 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #130 · Compounds › Cagrilintide & amylin analogues · 18 Jun 2025 · 1 like Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying and promotes satiety through a different receptor and different neural pathways. The…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #41 · Compounds › Repair & healing peptides · 16 Jun 2025 · 11 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #27 · Analytics › Home & field testing · 16 Jun 2025 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #24 · Analytics › Mass spectrometry · 2 Jun 2025 · 27 likes Coming back to post #22, because the follow-up matters more than the original answer. Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you…
-
Half-life, steady state, and accumulation worked through Replied, post #24 · Pharmacology › Pharmacokinetics · 26 May 2025 · 5 likes This follows post #21 rather than contradicting it. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is…
-
Travel coolers and how long they really hold — the long version Replied, post #9 · Devices › Cold chain · 20 May 2025 · 4 likes Coming back to post #7, because the follow-up matters more than the original answer. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #31 · Compounds › Oral incretins · 13 May 2025 · 10 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Food effects on oral incretin absorption: what is documented Replied, post #2 · Compounds › Oral incretins · 11 May 2025 · 14 likes Coming back to the opening post, because the follow-up matters more than the original answer. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an…
-
Lean mass preservation: what the evidence supports Replied, post #9 · Outcomes › Body composition · 9 May 2025 · 0 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #110 · Compounds › Semaglutide · 9 May 2025 · 5 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
Antibiotics and a course of something with delayed emptying Replied, post #32 · Practice › Interactions · 2 May 2025 · 23 likes Worth separating two things that post #28 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
A supplier that answers analytical questions with restated claims Replied, post #67 · Sourcing › Red flags · 30 Apr 2025 · 4 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
-
Reading an MS report that only gives you a single number Replied, post #56 · Analytics › Mass spectrometry · 18 Apr 2025 · 7 likes post #55 answers the question as asked. The question underneath it is different. Calibration matters: a high-resolution instrument out of calibration can report mass…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #130 · Access › International · 28 Mar 2025 · 6 likes This follows post #127 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #42 · Analytics › Mass spectrometry · 22 Mar 2025 · 5 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Follow-up: Journal club: the retatrutide phase 2 obesity paper Replied, post #7 · Evidence › Journal club · 20 Mar 2025 · 5 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Maintainer handover: how it works Replied, post #51 · Meta › Wiki maintenance · 17 Mar 2025 · 6 likes Worth separating two things that post #47 runs together. Redundancy: if two maintained pages cover largely the same ground, consolidation might improve clarity.…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #105 · Pharmacology › Receptor biology · 15 Mar 2025 · 24 likes On post #101 — agreed on the reasoning, with one qualification. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on neurons…
-
UK access routes, dated and sourced — a second dataset Replied, post #47 · Regional › UK & Ireland · 7 Mar 2025 · 0 likes Picking up post #44: that is the part I would want checked first. Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only.…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #132 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
Validating a method you did not develop — does this still hold? Replied, post #26 · Analytics › Method validation · 20 Feb 2025 · 4 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Reading an MS report that only gives you a single number Replied, post #12 · Analytics › Mass spectrometry · 17 Feb 2025 · 2 likes Resolution: "high resolution" commonly means
-
What we do not know about retatrutide, listed explicitly Replied, post #86 · Compounds › Retatrutide · 7 Feb 2025 · 0 likes post #85 is right about the mechanism and I think understates the practical bit. Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #4 · Sourcing › Red flags · 6 Feb 2025 · 1 like Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #21 · Practice › Interactions · 1 Feb 2025 · 0 likes Worth separating two things that post #17 runs together. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining…
-
Protein density versus volume when you cannot eat much Replied, post #44 · Nutrition & Training › Protein & intake · 31 Jan 2025 · 27 likes Worth separating two things that post #40 runs together. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #4 · Clinical › Bloodwork · 30 Jan 2025 · 1 like Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #93 · Compounds › Semaglutide · 27 Jan 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
When to suspect the method rather than the sample Replied, post #70 · Analytics › Method validation · 23 Jan 2025 · 25 likes I read post #68 twice before replying, because I had assumed the opposite. Stability-indicating method: one that can separate a compound from its degradation products.…
-
Identical chromatograms across two different lots Replied, post #79 · Sourcing › Red flags · 20 Jan 2025 · 1 like Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
-
Recovery when intake is low: what to cut first Replied, post #68 · Nutrition & Training › Resistance training · 13 Jan 2025 · 12 likes Picking up post #65: that is the part I would want checked first. Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #4 · Clinical › Bloodwork · 30 Dec 2024 · 0 likes Picking up the opening post: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #80 · Compounds › Semaglutide · 23 Dec 2024 · 22 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #160 · Analytics › COA interpretation · 22 Dec 2024 · 0 likes Picking up post #157: that is the part I would want checked first. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #76 · Access › Insurance & coverage · 18 Dec 2024 · 7 likes Appeals process: unemotional prose, the criterion quoted verbatim, evidence mapped to it point by point, dates, and nothing else. Describing how the decision affected…
-
Transit times by route, from a logged dataset — the long version Replied, post #40 · Sourcing › Logistics · 18 Dec 2024 · 0 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Revisiting: Moderation log format change Replied, post #45 · Meta › Announcements · 28 Nov 2024 · 15 likes Coming back to post #43, because the follow-up matters more than the original answer. Implementation timeline: announcements include when a change takes effect. Marking…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #66 · Compounds › Tirzepatide · 28 Nov 2024 · 25 likes Picking up post #63: that is the part I would want checked first. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
Fixed versus detachable needles: the trade-offs Replied, post #18 · Devices › Syringes & needles · 25 Nov 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A vial that will not fully dissolve: what to check and in what order Replied, post #6 · Practice › Reconstitution · 15 Nov 2024 · 0 likes This follows post #3 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #58 · Compounds › Repair & healing peptides · 15 Nov 2024 · 0 likes This follows post #55 rather than contradicting it. Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are…
-
Time to steady state after a dose increase Replied, post #135 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 17 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #21 · Clinical › Prescriber conversations · 1 Nov 2024 · 0 likes Picking up post #18: that is the part I would want checked first. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and…
-
Revisiting: Moderation log format change Replied, post #9 · Meta › Announcements · 28 Oct 2024 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #11 · Sourcing › Regulatory · 22 Oct 2024 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Gallbladder disease risk with rapid weight loss Replied, post #13 · Clinical › Comorbidities · 26 Sep 2024 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Promotion criteria, and the one that stops most nominations Replied, post #65 · Documentation › Doc review · 19 Sep 2024 · 4 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
When a red flag was a misunderstanding, and the retraction Replied, post #19 · Sourcing › Red flags · 19 Sep 2024 · 20 likes Coming back to post #17, because the follow-up matters more than the original answer. Rapid supplier turnover: a supplier that changes corporate structure, domain name,…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #16 · Clinical › Bloodwork · 8 Sep 2024 · 24 likes I read post #14 twice before replying, because I had assumed the opposite. Analytical imprecision: any measurement has an error margin. A small difference in…
-
Correlation in a self-tracked dataset: what it can support Replied, post #58 · Research Methods › Statistics · 22 Aug 2024 · 13 likes Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many…
-
Guidelines revision: what changed and why Replied, post #49 · Meta › Announcements · 26 Jul 2024 · 9 likes Coming back to post #47, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #88 · Practice › Dosing & titration · 9 Jul 2024 · 32 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #9 · Evidence › Journal club · 8 Jul 2024 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…